Nucleophosmin Phosphorylation by v-Cyclin-CDK6 Controls KSHV Latency
Nucleophosmin (NPM) is a multifunctional nuclear phosphoprotein and a histone chaperone implicated in chromatin organization and transcription control. Oncogenic Kaposi's sarcoma herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). In the infected host cell KSHV displays two modes of infection, the latency and productive viral replication phases, involving extensive viral DNA replication and gene expression. A sustained balance between latency and reactivation to the productive infection state is essential for viral persistence and KSHV pathogenesis. Our study demonstrates that the KSHV v-cyclin and cellular CDK6 kinase phosphorylate NPM on threonine 199 (Thr199) in de novo and naturally KSHV-infected cells and that NPM is phosphorylated to the same site in primary KS tumors. Furthermore, v-cyclin-mediated phosphorylation of NPM engages the interaction between NPM and the latency-associated nuclear antigen LANA, a KSHV-encoded repressor of viral lytic replication. Strikingly, depletion of NPM in PEL cells leads to viral reactivation, and production of new infectious virus particles. Moreover, the phosphorylation of NPM negatively correlates with the level of spontaneous viral reactivation in PEL cells. This work demonstrates that NPM is a critical regulator of KSHV latency via functional interactions with v-cyclin and LANA.
Vyšlo v časopise:
Nucleophosmin Phosphorylation by v-Cyclin-CDK6 Controls KSHV Latency. PLoS Pathog 6(3): e32767. doi:10.1371/journal.ppat.1000818
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000818
Souhrn
Nucleophosmin (NPM) is a multifunctional nuclear phosphoprotein and a histone chaperone implicated in chromatin organization and transcription control. Oncogenic Kaposi's sarcoma herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). In the infected host cell KSHV displays two modes of infection, the latency and productive viral replication phases, involving extensive viral DNA replication and gene expression. A sustained balance between latency and reactivation to the productive infection state is essential for viral persistence and KSHV pathogenesis. Our study demonstrates that the KSHV v-cyclin and cellular CDK6 kinase phosphorylate NPM on threonine 199 (Thr199) in de novo and naturally KSHV-infected cells and that NPM is phosphorylated to the same site in primary KS tumors. Furthermore, v-cyclin-mediated phosphorylation of NPM engages the interaction between NPM and the latency-associated nuclear antigen LANA, a KSHV-encoded repressor of viral lytic replication. Strikingly, depletion of NPM in PEL cells leads to viral reactivation, and production of new infectious virus particles. Moreover, the phosphorylation of NPM negatively correlates with the level of spontaneous viral reactivation in PEL cells. This work demonstrates that NPM is a critical regulator of KSHV latency via functional interactions with v-cyclin and LANA.
Zdroje
1. BorerRA
LehnerCF
EppenbergerHM
NiggEA
1989 Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56 379 390
2. GrisendiS
MecucciC
FaliniB
PandolfiPP
2006 Nucleophosmin and cancer. Nat Rev Cancer 6 493 505
3. OkudaM
HornHF
TaraporeP
TokuyamaY
SmulianAG
2000 Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103 127 140
4. TokuyamaY
HornHF
KawamuraK
TaraporeP
FukasawaK
2001 Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J Biol Chem 276 21529 21537
5. AblashiDV
ChatlynneLG
WhitmanJEJr
CesarmanE
2002 Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15 439 464
6. ZhongW
WangH
HerndierB
GanemD
1996 Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A 93 6641 6646
7. DittmerDP
2003 Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63 2010 2015
8. RenneR
ZhongW
HerndierB
McGrathM
AbbeyN
1996 Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2 342 346
9. MillerG
El-GuindyA
CountrymanJ
YeJ
GradovilleL
2007 Lytic cycle switches of oncogenic human gammaherpesviruses(1). Adv Cancer Res 97 81 109
10. BallestasME
KayeKM
2001 Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75 3250 3258
11. BarberaAJ
ChodaparambilJV
Kelley-ClarkeB
JoukovV
WalterJC
2006 The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311 856 861
12. BallestasME
ChatisPA
KayeKM
1999 Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 641 644
13. YeFC
ZhouFC
YooSM
XieJP
BrowningPJ
2004 Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J Virol 78 11121 11129
14. LanK
KuppersDA
VermaSC
RobertsonES
2004 Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J Virol 78 6585 6594
15. LanK
KuppersDA
RobertsonES
2005 Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. J Virol 79 3468 3478
16. GarberAC
ShuMA
HuJ
RenneR
2001 DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75 7882 7892
17. VermaSC
LanK
ChoudhuriT
RobertsonES
2006 Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats. J Virol 80 3445 3458
18. AnFQ
CompitelloN
HorwitzE
SramkoskiM
KnudsenES
2005 The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 280 3862 3874
19. DittmerD
LagunoffM
RenneR
StaskusK
HaaseA
1998 A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72 8309 8315
20. GrundhoffA
GanemD
2001 Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J Virol 75 1857 1863
21. PearceM
MatsumuraS
WilsonAC
2005 Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol 79 14457 14464
22. MittnachtS
BoshoffC
2000 Viral cyclins. Rev Med Virol 10 175 184
23. VerschurenEW
JonesN
EvanGI
2004 The cell cycle and how it is steered by Kaposi's sarcoma-associated herpesvirus cyclin. J Gen Virol 85 1347 1361
24. JarviluomaA
OjalaPM
2006 Cell signaling pathways engaged by KSHV. Biochim Biophys Acta 1766 140 158
25. KurkiS
PeltonenK
LatonenL
KiviharjuTM
OjalaPM
2004 Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5 465 475
26. SarekG
JarviluomaA
OjalaPM
2006 KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 107 725 732
27. CuomoME
KnebelA
MorriceN
PatersonH
CohenP
2008 p53-Driven apoptosis limits centrosome amplification and genomic instability downstream of NPM1 phosphorylation. Nat Cell Biol 10 723 730
28. OkuwakiM
TsujimotoM
NagataK
2002 The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Mol Biol Cell 13 2016 2030
29. TaraporeP
ShinmuraK
SuzukiH
TokuyamaY
KimSH
2006 Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing. FEBS Lett 580 399 409
30. VieiraJ
O'HearnPM
2004 Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325 225 240
31. GodfreyA
AndersonJ
PapanastasiouA
TakeuchiY
BoshoffC
2005 Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105 2510 2518
32. TalbotSJ
WeissRA
KellamP
BoshoffC
1999 Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257 84 94
33. KellerSA
SchattnerEJ
CesarmanE
2000 Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96 2537 2542
34. GuasparriI
KellerSA
CesarmanE
2004 KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199 993 1003
35. PlattGM
CannellE
CuomoME
SinghS
MittnachtS
2000 Detection of the human herpesvirus 8-encoded cyclin protein in primary effusion lymphoma-derived cell lines. Virology 272 257 266
36. JarviluomaA
KoopalS
RasanenS
MakelaTP
OjalaPM
2004 KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas. Blood 104 3349 3354
37. RaneSG
DubusP
MettusRV
GalbreathEJ
BodenG
1999 Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 22 44 52
38. TsutsuiT
HesabiB
MoonsDS
PandolfiPP
HanselKS
1999 Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol 19 7011 7019
39. MalumbresM
SotilloR
SantamariaD
GalanJ
CerezoA
2004 Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118 493 504
40. SiH
VermaSC
RobertsonES
2006 Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins. J Virol 80 9017 9030
41. LiuH
TanBC
TsengKH
ChuangCP
YehCW
2007 Nucleophosmin acts as a novel AP2alpha-binding transcriptional corepressor during cell differentiation. EMBO Rep 8 394 400
42. LuF
DayL
GaoSJ
LiebermanPM
2006 Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J Virol 80 5273 5282
43. SwaminathanV
KishoreAH
FebithaKK
KunduTK
2005 Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription. Mol Cell Biol 25 7534 7545
44. ChengF
Weidner-GlundeM
VarjosaloM
RainioEM
LehtonenA
2009 KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA. PLoS Pathog 5 e1000324 doi:10.1371/journal.ppat.1000324
45. GwackY
ByunH
HwangS
LimC
ChoeJ
2001 CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J Virol 75 1909 1917
46. WaltonTH
MoenPTJr
FoxE
BodnarJW
1989 Interactions of minute virus of mice and adenovirus with host nucleoli. J Virol 63 3651 3660
47. MatthewsDA
2001 Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm. J Virol 75 1031 1038
48. BevingtonJM
NeedhamPG
VerrillKC
CollacoRF
BasrurV
2007 Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions. Virology 357 102 113
49. QiW
ShakalyaK
StejskalA
GoldmanA
BeeckS
2008 NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene 27 4210 4220
50. JianY
GaoZ
SunJ
ShenQ
FengF
2009 RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells. Oncogene 28 4201 4211
51. CesarmanE
MoorePS
RaoPH
InghiramiG
KnowlesDM
1995 In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86 2708 2714
52. CannonJS
CiufoD
HawkinsAL
GriffinCA
BorowitzMJ
2000 A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 74 10187 10193
53. ArvanitakisL
MesriEA
NadorRG
SaidJW
AschAS
1996 Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88 2648 2654
54. SarekG
KurkiS
EnbackJ
IotzovaG
HaasJ
2007 Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. J Clin Invest 117 1019 1028
55. KoopalS
FuruhjelmJH
JarviluomaA
JaamaaS
PyakurelP
2007 Viral oncogene-induced DNA damage response is activated in Kaposi sarcoma tumorigenesis. PLoS Pathog 3 1348 1360
56. DittmerD
StoddartC
RenneR
Linquist-SteppsV
MorenoME
1999 Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J Exp Med 190 1857 1868
57. FakhariFD
DittmerDP
2002 Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 76 6213 6223
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 3
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein Binds and Protects a Nuclear Noncoding RNA from Cellular RNA Decay Pathways
- Endocytosis of the Anthrax Toxin Is Mediated by Clathrin, Actin and Unconventional Adaptors
- Perforin and IL-2 Upregulation Define Qualitative Differences among Highly Functional Virus-Specific Human CD8 T Cells
- Inhibition of Macrophage Migration Inhibitory Factor Ameliorates Ocular -Induced Keratitis